Latest 10-Q quarterly reports
AMEX
Hyperscale Data reports Q1 2026 financial results, highlighting a net loss of $30.1 million amid ongoing strategic restructuring.
OTC.Pink
Madison Technologies reports zero revenue and a $660,455 net loss for Q1 2026, while maintaining a going concern warning due to significant debt and working capital deficits.
NASDAQ
CBAK Energy Technology, Inc. saw revenues nearly double in Q1 2026, but reported a substantial increase in net loss and operating loss.
NYSE
BALY
Bally's CORPBally's Corporation announced its financial results for the first quarter of 2026, detailing revenue, operating costs, and net loss.
NASDAQ
AMST
Amesite INCAmesite Inc. reported increased revenue and reduced net loss for the nine months ended March 31, 2026, while addressing Nasdaq listing compliance.
ENvue Medical, Inc. reported a significant revenue decrease for the first quarter of 2026, primarily due to the market removal of a key product, while also highlighting ongoing liquidity concerns.
AMEX
CleanCore Solutions, Inc. filed an amended quarterly report for the period ended March 31, 2026, detailing significant operational losses, a substantial increase in general and administrative expenses, and ongoing concerns about its ability to continue as a going concern.
OQB
Tofutti Brands reports a 2% decrease in net sales for Q1 2026, alongside significant operational challenges including the impending closure of its primary co-packer facility.
NASDAQ
ALTS
Alt5 Sigma CORPAI Financial Corporation (AIFC) filed its Form 10-Q for the quarter ended March 28, 2026, reporting a substantial net loss driven by unrealized losses on cryptocurrency assets, while its Fintech segment showed improved gross margins.
NASDAQ
BTBD
Bt Brands, INCBT Brands Inc. reported a net loss of $751,011 for the first quarter of fiscal 2026, with sales down to $2.8 million, while also announcing the termination of its proposed merger with Aero Velocity.
Crown PropTech Acquisitions reports Q1 2026 results, detailing ongoing business combination efforts and financial status.
NASDAQ
NewHold Investment Corp III reports net income of $704,000 for Q1 2026, driven by interest income, while general and administrative expenses increased significantly.
AMEX
Catheter Precision, Inc. reported its Q1 2026 financial results, highlighting increased revenues from its cardiac electrophysiology and private aviation segments following the acquisition of FLYTE.
NASDAQ
ABVC BioPharma, Inc. reported a net loss of $1.69 million for the first quarter of 2026, a significant increase from the prior year's loss, with no revenue generated.
NYSE
BRC
Brady CORPBrady Corporation announced robust financial results for its third quarter ended April 30, 2026, driven by strong organic sales growth and the successful integration of recent acquisitions, alongside progress on its transformative PSS business acquisition.
AMEX
OSTX
Os Therapies INCOS Therapies Inc. reported its first quarter 2026 financial results, highlighting significant increases in research and development expenses and continued net losses, while advancing its OST-HER2 therapy towards regulatory submissions.
NASDAQ
Versus Systems reports Q1 2026 results, disclosing a net loss of $0.8 million, ongoing going concern doubts, and a $0.8 million internal fraud investigation.
NASDAQ
Alaunos Therapeutics reports Q1 2026 net loss of $1.0 million while highlighting preclinical progress for its obesity program, ALN1003.
NASDAQ
ITHAX Acquisition Corp III reports net income of $1.78 million for the first quarter of 2026 as it continues its search for an initial business combination.
NASDAQ
DAIO
Data I/o CORPData I/O Corporation reports a net loss of $3.17 million for Q1 2026 amid challenging global economic conditions and strategic restructuring.
NASDAQ
Generation Income Properties reports Q1 2026 net loss of $1.27 million while addressing going concern and Nasdaq listing challenges.
NASDAQ
Silexion Therapeutics reports Q1 2026 financial results, highlighting ongoing clinical development of SIL204 and significant capital raising efforts to address going concern risks.
NASDAQ
TuHURA Biosciences reports Q1 2026 financial results, highlighting a $7.5 million net loss and a new $50 million credit facility to support clinical development.
NASDAQ
BioNexus Gene Lab Corp. reports a significant revenue decline for Q1 2026 amid internal control remediation and legal action against former management.
Amaze Holdings reports Q1 2026 financial results, highlighting a significant net loss and ongoing going concern risks.
NASDAQ
Pioneer Power Solutions reports a net loss of $2.5 million for Q1 2026 amid a 36.7% decline in quarterly revenue.
NASDAQ
ClearThink 1 Acquisition Corp. reports its Q1 2026 financial results following the completion of its initial public offering.
NASDAQ
ATER
Aterian, INCAterian, Inc. has entered into a definitive agreement to sell its marquee brands for $18 million and secured a $7 million capital infusion to address liquidity concerns.
OTC.Pink
byNordic Acquisition Corporation reports a net loss of $505,855 for Q1 2026 as it continues to seek a business combination target.
NASDAQ
XSLL
Xsolla Spac 1Xsolla SPAC 1 reports $205.4 million in trust assets for the first quarter of 2026 as it continues its search for a business combination target.